This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S

C17H20F2N4O3S, triclinic, P1 (no. 1), a = 6.0020(12) Å, b = 6.7650(14) Å, c = 11.831(2) Å, α = 89.39(3)°, β = 86.29(3)°, γ = 66.50(3)°, V = 439.55(15) Å3, Z = 1, Rgt(F) = 0.0543, wRref(F2) = 0.1568, T = 293(2) K.

Bibliographic Details
Main Authors: Wang Kun-Yan, Yang Xiao-Li
Format: Article
Language:English
Published: De Gruyter 2016-09-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Subjects:
Online Access:https://doi.org/10.1515/ncrs-2015-0260
id doaj-441c6d347d3049128a63535bca0ebb22
record_format Article
spelling doaj-441c6d347d3049128a63535bca0ebb222021-09-06T19:20:47ZengDe GruyterZeitschrift für Kristallographie - New Crystal Structures1433-72662197-45782016-09-01231376376510.1515/ncrs-2015-0260This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3SWang Kun-Yan0Yang Xiao-Li1School of Material Engineering, Jinling Institute of Technology, Nanjing 210000, P. R. ChinaSchool of Material Engineering, Jinling Institute of Technology, Nanjing 210000, P. R. ChinaC17H20F2N4O3S, triclinic, P1 (no. 1), a = 6.0020(12) Å, b = 6.7650(14) Å, c = 11.831(2) Å, α = 89.39(3)°, β = 86.29(3)°, γ = 66.50(3)°, V = 439.55(15) Å3, Z = 1, Rgt(F) = 0.0543, wRref(F2) = 0.1568, T = 293(2) K.https://doi.org/10.1515/ncrs-2015-02601463122
collection DOAJ
language English
format Article
sources DOAJ
author Wang Kun-Yan
Yang Xiao-Li
spellingShingle Wang Kun-Yan
Yang Xiao-Li
This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
Zeitschrift für Kristallographie - New Crystal Structures
1463122
author_facet Wang Kun-Yan
Yang Xiao-Li
author_sort Wang Kun-Yan
title This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
title_short This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
title_full This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
title_fullStr This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
title_full_unstemmed This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
title_sort this molecule targets at type 2 diabetes - a single crystal study on (2r,3s,5r)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl] tetrahydro-2h-pyran-3-amine (omarigliptin), c17h20f2n4o3s
publisher De Gruyter
series Zeitschrift für Kristallographie - New Crystal Structures
issn 1433-7266
2197-4578
publishDate 2016-09-01
description C17H20F2N4O3S, triclinic, P1 (no. 1), a = 6.0020(12) Å, b = 6.7650(14) Å, c = 11.831(2) Å, α = 89.39(3)°, β = 86.29(3)°, γ = 66.50(3)°, V = 439.55(15) Å3, Z = 1, Rgt(F) = 0.0543, wRref(F2) = 0.1568, T = 293(2) K.
topic 1463122
url https://doi.org/10.1515/ncrs-2015-0260
work_keys_str_mv AT wangkunyan thismoleculetargetsattype2diabetesasinglecrystalstudyon2r3s5r225difluorophenyl52methylsulfonyl26dihydropyrrolo34cpyrazol54hyltetrahydro2hpyran3amineomarigliptinc17h20f2n4o3s
AT yangxiaoli thismoleculetargetsattype2diabetesasinglecrystalstudyon2r3s5r225difluorophenyl52methylsulfonyl26dihydropyrrolo34cpyrazol54hyltetrahydro2hpyran3amineomarigliptinc17h20f2n4o3s
_version_ 1717775999616155648